Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL193 (Slofedipine xl 30, Angiopine 10, BAY-A-1040, Nivaten ret, Valni xl, Hypolar ret 20, Nifedipress mr 20, Adipine xl, Genalat 10 ret, Nimodrel mr 20, Nifensar xl, Fortipine la40, Nifedipine hydrochloride, Procardia xl, Adalat cc, Slofedipine xl 60, Kentipine mr 20, Adalat la 20, Kentipine mr 10, Nifelease, Calanif, Kentipine, Angiopine 40 la, Nifedipinum, Nifopress mr, BAY A 1040, Nifedipine, Nife-wolff, Adalat ret, Adipine mr 20, Nifedotard 20 mr, Tensipine mr 10, Hypolar ret 10, Adipine mr 10, Adalate lp, Angiopine mr 10, Genalat 20 ret, Angiopine 5, Adalat, Cardilate mr, Nimodrel xl, Nimodrel mr 10, Procardia, Calchan mr 10, Unipine xl, Adalat la 30, Calchan mr 20, Vasad, Coracten, Tensipine mr 20, Valni 20 ret, Adalat la 60, Adalat a.r., Nifedipino, Nifedipress mr 10, Coroday mr, Hypolar xl 30, Angiopine mr 20, Neozipine xl, Coracten sr, Coracten xl, Nifedipine slow release, Nifopress ret, Afeditab cr, Calcilat, NSC-757242, Adalat ic, Adanif xl) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| 5-HT2C receptor/5-hydroxytryptamine receptor 2C in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
| ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 5.02 | pKi | 9572 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 4.74 | pIC50 | 18273 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| Acetylcholinesterase in Electrophorus electricus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4078] [UniProtKB: O42275] | ||||||||
| ChEMBL | Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method | B | 5.4 | pKi | 4000 | nM | Ki | Med Chem Res (2005) 14: 297-308 |
| A1 receptor/Adenosine receptor A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
| ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 5.35 | pKi | 4492 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 5.11 | pIC50 | 7701 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| A1 receptor/Adenosine receptor A1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL318] [GtoPdb: 18] [UniProtKB: P25099] | ||||||||
| ChEMBL | Displacement of [3H](R)-PIA binding to Adenosine A1 receptor in rat brain membranes | B | 5 | pKi | <10000 | nM | Ki | J Med Chem (1996) 39: 2980-2989 [PMID:8709132] |
| ChEMBL | Binding affinity against adenosine A1 receptor in rat cerebral cortex membrane by radioligand binding assay using [3H](R)-PIA. | B | 5.54 | pKi | 2890 | nM | Ki | J Med Chem (1996) 39: 4667-4675 [PMID:8917655] |
| ChEMBL | Displacement of [3H](R)-PIA binding to Adenosine A1 receptor in rat brain membranes | B | 5.54 | pKi | 2890 | nM | Ki | J Med Chem (1996) 39: 2980-2989 [PMID:8709132] |
| A2A receptor/Adenosine receptor A2a in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274] | ||||||||
| ChEMBL | Binding affinity for HA-tagged mutant human Adenosine A2A receptor (V84L), using [3H]CGS-21680 as radioligand expressed in COS-7 cells | B | 4.65 | pKi | 22200 | nM | Ki | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
| ChEMBL | Binding affinity for HA-tagged mutant human Adenosine A2A receptor (H250N) using [3H]-CGS-21,680 as radioligand expressed in COS-7 cells | B | 4.65 | pKi | 22200 | nM | Ki | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
| A2A receptor/Adenosine receptor A2a in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL302] [GtoPdb: 19] [UniProtKB: P30543] | ||||||||
| ChEMBL | Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes | B | 4.74 | pKi | 18200 | nM | Ki | J Med Chem (1996) 39: 2980-2989 [PMID:8709132] |
| ChEMBL | Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes | B | 5 | pKi | <10000 | nM | Ki | J Med Chem (1996) 39: 2980-2989 [PMID:8709132] |
| A3 receptor/Adenosine receptor A3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8] | ||||||||
| ChEMBL | Displacement of [125]AB-MECA binding to human Adenosine A3 receptor expressed in HEK cells | B | 5 | pKi | <10000 | nM | Ki | J Med Chem (1996) 39: 2980-2989 [PMID:8709132] |
| ChEMBL | Inhibition of [125I]- AB-MECA binding to human Adenosine A3 receptors expressed in HEK cells | B | 5.08 | pKi | 8290 | nM | Ki | J Med Chem (1996) 39: 4667-4675 [PMID:8917655] |
| ChEMBL | Displacement of [125]AB-MECA binding to human Adenosine A3 receptor expressed in HEK cells | B | 5.08 | pKi | 8290 | nM | Ki | J Med Chem (1996) 39: 2980-2989 [PMID:8709132] |
| ChEMBL | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | B | 5.39 | pKi | 4078 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | B | 5.14 | pIC50 | 7214 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| ABCB11/Bile salt export pump in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6020] [GtoPdb: 778] [UniProtKB: O95342] | ||||||||
| ChEMBL | Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake | B | 4.51 | pIC50 | 30700 | nM | IC50 | Drug Metab Dispos (2012) 40: 130-138 [PMID:21965623] |
| ABCB11/Bile salt export pump in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073674] [GtoPdb: 778] [UniProtKB: O70127] | ||||||||
| ChEMBL | Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake | B | 4.34 | pIC50 | 45400 | nM | IC50 | Drug Metab Dispos (2012) 40: 130-138 [PMID:21965623] |
| ABCG2/Broad substrate specificity ATP-binding cassette transporter ABCG2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
| ChEMBL | Inhibition of human ABCG2 expressed in human HEK293 cells mediated pheophorbide A efflux assessed as intracellular pheophorbide A accumulation for 45 mins by FACSort flow cytometry | B | 4.3 | pIC50 | 50500 | nM | IC50 | Eur J Med Chem (2022) 237: 114346-114346 [PMID:35483322] |
| CCR2/C-C chemokine receptor type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4015] [GtoPdb: 59] [UniProtKB: P41597] | ||||||||
| ChEMBL | DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) | B | 6.07 | pKi | 847 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) | B | 5.66 | pIC50 | 2191 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| Cholinesterase in Equus caballus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5763] [UniProtKB: P81908] | ||||||||
| ChEMBL | Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method | B | 5.3 | pKi | 5011.87 | nM | Ki | Med Chem Res (2005) 14: 297-308 |
| ChEMBL | Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method | B | 5.92 | pKi | 1200 | nM | Ki | Med Chem Res (2005) 14: 297-308 |
| CYP1A2/Cytochrome P450 1A2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3356] [GtoPdb: 1319] [UniProtKB: P05177] | ||||||||
| ChEMBL | DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | B | 6.52 | pIC50 | 300 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| CYP3A4/Cytochrome P450 3A4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL340] [GtoPdb: 1337] [UniProtKB: P08684] | ||||||||
| ChEMBL | Inhibition of CYP3A4 in human liver microsome | B | 4.96 | pIC50 | 11000 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 1206-1213 [PMID:21256005] |
| phosphodiesterase 1C/Dual specificity calcium/calmodulin-dependent 3`,5`-cyclic nucleotide phosphodiesterase 1C in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4619] [GtoPdb: 1296] [UniProtKB: Q14123] | ||||||||
| ChEMBL | Inhibition of PDE1C (147 to 531 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cGMP as substrate measured for 15 mins by liquid scintillation counter method | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 8444-8455 [PMID:35666471] |
| glutathione-disulfide reductase/Glutathione reductase, mitochondrial in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2755] [GtoPdb: 2613] [UniProtKB: P00390] | ||||||||
| ChEMBL | Competitive inhibition of human erythrocyte Glutathione reductase using GSSG substrate by Lineweaver-Burk plot analysis | B | 4.76 | pKi | 17400 | nM | Ki | Bioorg Med Chem Lett (2011) 21: 5398-5402 [PMID:21795044] |
| ChEMBL | Inhibition of human erythrocyte Glutathione reductase | B | 4.63 | pIC50 | 23400 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 5398-5402 [PMID:21795044] |
| indoleamine 2,3-dioxygenase 1/Indoleamine 2,3-dioxygenase 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075294] [GtoPdb: 2829] [UniProtKB: P28776] | ||||||||
| ChEMBL | Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis | B | 4.34 | pIC50 | 46000 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 7641-7646 [PMID:23122865] |
| indoleamine 2,3-dioxygenase 2/Indoleamine 2,3-dioxygenase 2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2189159] [GtoPdb: 3019] [UniProtKB: Q8R0V5] | ||||||||
| ChEMBL | Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis | B | 5.82 | pIC50 | 1500 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 7641-7646 [PMID:23122865] |
| myosin light chain kinase/Myosin light chain kinase, smooth muscle in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2428] [GtoPdb: 1552] [UniProtKB: Q15746] | ||||||||
| ChEMBL | Inhibition of MLCK (unknown origin) incubated for 15 mins using [gamma-32P]-ATP by scintillation counting method | B | 5.69 | pIC50 | 2020 | nM | IC50 | Bioorg Med Chem (2015) 23: 6689-6713 [PMID:26385444] |
| Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay | F | 5 | pIC50 | 10000 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | F | 5 | pIC50 | 10000 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | F | 5.1 | pIC50 | 7943.28 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| Polyunsaturated fatty acid lipoxygenase ALOX15 in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4358] [UniProtKB: P12530] | ||||||||
| ChEMBL | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | B | 4.82 | pIC50 | 15101 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| Potassium channel subfamily K member 2 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075183] [UniProtKB: Q8HY88] | ||||||||
| ChEMBL | Activation of bovine TREK1 expressed in AZT cells assessed as reduction in channel currents | B | 5.09 | pIC50 | 8200 | nM | IC50 | J Med Chem (2016) 59: 5149-5157 [PMID:26588045] |
| Kv1.1/Potassium voltage-gated channel subfamily A member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2309] [GtoPdb: 538] [UniProtKB: Q09470] | ||||||||
| ChEMBL | Inhibition of Kv1.1 (unknown origin) | B | 4.02 | pIC50 | 96000 | nM | IC50 | J Med Chem (2017) 60: 2245-2256 [PMID:28225274] |
| Kv1.1 in Mouse [GtoPdb: 538] [UniProtKB: P16388] | ||||||||
| GtoPdb | - | - | 4 | pIC50 | - | - | - | Mol Pharmacol (1994) 45: 1227-34 [PMID:7517498] |
| Kv1.5/Potassium voltage-gated channel subfamily A member 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4306] [GtoPdb: 542] [UniProtKB: P22460] | ||||||||
| GtoPdb | - | - | 4.1 | pKd | - | - | - | Mol Pharmacol (1994) 45: 1227-34 [PMID:7517498] |
| ChEMBL | Inhibition of human Kv1.5 channel expressed in mouse L929 cells by EP voltage clamp technique | B | 5.21 | pIC50 | 6100 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 6381-6385 [PMID:19004630] |
| CYP5A1/Thromboxane-A synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1835] [GtoPdb: 1353] [UniProtKB: P24557] | ||||||||
| ChEMBL | DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) | B | 4.73 | pIC50 | 18594 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| CYP5A1/Thromboxane-A synthase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4028] [GtoPdb: 1353] [UniProtKB: P49430] | ||||||||
| ChEMBL | In vitro inhibition of thromboxane B2 production in rat whole blood. | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (1993) 36: 2964-2972 [PMID:8411014] |
| TRPA1/Transient receptor potential cation channel subfamily A member 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075310] [GtoPdb: 485] [UniProtKB: Q8BLA8] | ||||||||
| ChEMBL | Agonist activity at mouse TRPA1 channel expressed in CHO cells assessed as increase in intracellular calcium influx | F | 6.4 | pEC50 | 400 | nM | EC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| Translocator protein in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4552] [GtoPdb: 2879] [UniProtKB: P16257] | ||||||||
| ChEMBL | Inhibition of rat TSPO | B | 9.3 | pIC50 | 0.5 | nM | IC50 | Eur J Med Chem (2024) 267: 116117-116117 [PMID:38295689] |
| Cav1.2/Voltage-dependent L-type calcium channel subunit alpha-1C in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1940] [GtoPdb: 529] [UniProtKB: Q13936] | ||||||||
| ChEMBL | Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes | B | 9.4 | pKd | 0.4 | nM | Kd | J Med Chem (1995) 38: 119-129 [PMID:7837222] |
| ChEMBL | Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles | B | 9 | pKi | 1 | nM | Ki | J Med Chem (1987) 30: 690-695 [PMID:2435904] |
| ChEMBL | Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit | F | 7.26 | pIC50 | 55 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
| ChEMBL | Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Chinese hamster ovary cells heterologically expressing alpha-1C subunit | F | 7.3 | pIC50 | 50 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
| ChEMBL | Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit | F | 7.66 | pIC50 | 22 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
| Voltage-dependent L-type calcium channel subunit alpha-1C in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2830] [UniProtKB: P15381] | ||||||||
| ChEMBL | Blockade of calcium-evoked contractions in depolarized aortic strips | F | 8.54 | pIC50 | 2.9 | nM | IC50 | J Med Chem (1992) 35: 2407-2414 [PMID:1377748] |
| ChEMBL | Inhibition of [3H]nitrendipine binding to calcium channels in Rabbit cardiac muscle. | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (1988) 31: 2221-2227 [PMID:3184128] |
| Cav1.2/Voltage-dependent L-type calcium channel subunit alpha-1C in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3762] [GtoPdb: 529] [UniProtKB: P22002] | ||||||||
| ChEMBL | Inhibition of [3H](+)-PN200-110 binding to L-type calcium channel 1,4-DHP binding site of rat ventricular myocytes | B | 8.46 | pKi | 3.5 | nM | Ki | J Med Chem (1993) 36: 3743-3745 [PMID:8246246] |
| GtoPdb | guinea pig, human stem cell-derived cardiomyocytes | - | 8.7 | pIC50 | 2 | nM | IC50 |
Am J Physiol Heart Circ Physiol (2000) 279: H2259-68 [PMID:11045961]; J Cardiovasc Pharmacol (1993) 22: 768-75 [PMID:7506331] |
| ChEMBL | Inhibition of rat Cav1.2 channel in rat mesenteric artery assessed as relaxation of 70 mM K+ induced contraction | B | 8.85 | pIC50 | 1.42 | nM | IC50 | J Med Chem (2014) 57: 4313-4323 [PMID:24754640] |
| Voltage-dependent L-type calcium channel subunit alpha-1C in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366456] [UniProtKB: O35505] | ||||||||
| ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes | F | 6.52 | pIC50 | 300 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
| ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes | F | 6.59 | pIC50 | 260 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
| ChEMBL | Inhibition of Calcium channel in Cavia porcellus albino (guinea pig) ileocecal SMC assessed as inhibition of 80 mM KCl-induced contraction | B | 7.16 | pIC50 | 69 | nM | IC50 | Med Chem Res (2012) 21: 284-292 |
| ChEMBL | Antagonist activity at Calcium channel in Cavia porcellus (guinea pig) ileal smooth muscle assessed as inhibition of 40 mM KCl-induced contraction compound pretreated for 15 min before KCl treatment | B | 7.3 | pIC50 | 50 | nM | IC50 | Med Chem Res (2009) 18: 112-126 |
| ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes | F | 7.3 | pIC50 | 50 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
| ChEMBL | Antagonist activity at Cavia porcellus albino (guinea pig) calcium channel assessed as inhibition of KCl-induced ileal longitudinal smooth muscle contraction | B | 8.59 | pIC50 | 2.6 | nM | IC50 | Med Chem Res (2012) 21: 2749-2761 |
| Cav1.3/Voltage-dependent L-type calcium channel subunit alpha-1D in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4138] [GtoPdb: 530] [UniProtKB: Q01668] | ||||||||
| ChEMBL | Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay | B | 5.87 | pIC50 | 1350 | nM | IC50 | J Med Chem (2014) 57: 4313-4323 [PMID:24754640] |
| GtoPdb | Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells | - | 7.7 | pIC50 | 20.1 | nM | IC50 | Mol Pharmacol (2009) 75: 407-14 [PMID:19029287] |
| Cav1.3/Voltage-dependent L-type calcium channel subunit alpha-1D in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4132] [GtoPdb: 530] [UniProtKB: P27732] | ||||||||
| ChEMBL | Binding affinity for L-type [Ca2+] channels was measured through displacement of [3H]nitrendipine on rat cortex homogenates. | B | 8.92 | pKi | 1.2 | nM | Ki | J Med Chem (1998) 41: 5393-5401 [PMID:9876109] |
| ChEMBL | Inhibitory concentration for L-type [Ca2+] channels was measured through displacement of [3H]nitrendipine on rat cortex homogenates. | B | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (1998) 41: 5393-5401 [PMID:9876109] |
| Kv11.1/Voltage-gated inwardly rectifying potassium channel KCNH2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
| ChEMBL | Inhibition of human Potassium channel HERG expressed in mammalian cells | B | 4.3 | pIC50 | 50118.72 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2773-2775 [PMID:12873512] |
| ChEMBL | Inhibitory concentration against potassium channel HERG | B | 4.3 | pIC50 | 50118.72 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 2886-2890 [PMID:15911273] |
| ChEMBL | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | B | 4.3 | pIC50 | 50118.72 | nM | IC50 | Bioorg Med Chem (2008) 16: 6252-6260 [PMID:18448342] |
| ChEMBL | Inhibition of human ERG | B | 4.3 | pIC50 | 50118.72 | nM | IC50 | Eur J Med Chem (2011) 46: 618-630 [PMID:21185626] |
| glycine receptor α1 subunit in Human [GtoPdb: 423] [UniProtKB: P23415] | ||||||||
| GtoPdb | - | - | 5.5 | pIC50 | 3300 | nM | IC50 | |
| glycine receptor α3 subunit in Human [GtoPdb: 425] [UniProtKB: O75311] | ||||||||
| GtoPdb | - | - | 4.5 | pIC50 | 29200 | nM | IC50 | |
| glycine receptor β subunit in Human [GtoPdb: 427] [UniProtKB: P48167] | ||||||||
| GtoPdb | - | - | 4.9 | pIC50 | 11400 | nM | IC50 | |
| GtoPdb | - | - | 5.9 | pIC50 | 1200 | nM | IC50 | |
| Cav1.1 in Rat [GtoPdb: 528] [UniProtKB: Q02485] | ||||||||
| GtoPdb | - | - | 6.3 | pIC50 | - | - | - | J Physiol (Lond.) (1987) 393: 595-617 [PMID:2451745] |
| Cav1.4 in Human [GtoPdb: 531] [UniProtKB: O60840] | ||||||||
| GtoPdb | - | - | 6 | pIC50 | - | - | - | J Neurosci (2004) 24: 1707-18 [PMID:14973233] |
| Kv1.2 in Rat [GtoPdb: 539] [UniProtKB: P63142] | ||||||||
| GtoPdb | - | - | 4.7 | pKd | 18000 | nM | Kd | Mol Pharmacol (1994) 45: 1227-34 [PMID:7517498] |
| Kv1.7 in Mouse [GtoPdb: 544] [UniProtKB: Q17ST2] | ||||||||
| GtoPdb | - | - | 4.9 | pIC50 | - | - | - | J Biol Chem (1998) 273: 5851-7 [PMID:9488722] |
| Kv3.1 in Mouse [GtoPdb: 548] [UniProtKB: P15388] | ||||||||
| GtoPdb | - | - | 3.9 | pIC50 | - | - | - | Mol Pharmacol (1994) 45: 1227-34 [PMID:7517498] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]